4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-031082
Chief Scientific Officer sold 7,090 shares at an average $35.58 ($252,247)
- Chief Scientific Officer acquired 7,790 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-05 | Exercise or conversion : show line 1 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-05-05 | Sale : show line 2 in the form | −3,195 | $35.43 | $113,199 | 69,360 | D |
| 2021-05-06 | Exercise or conversion : show line 3 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-05-06 | Sale : show line 4 in the form | −3,048 | $35.51 | $108,234 | 70,207 | D |
| 2021-05-06 | Sale : show line 5 in the form | −847 | $36.38 | $30,814 | 69,360 | D |
| Open-market sales · 7,090 sh · avg $35.58 · $252,247 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-05-05 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −3,895 | 132,430 | D |
| 2021-05-06 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −3,895 | 128,535 | D |
Loading xslF345X03/doc4.xml…